SME Regulation and reports
Submitted by Anonymous (not verified) on 28 May 2026 - 14:55
SME Regulation and reports
20 years supporting small and medium enterprises (SMEs) at EMA report
Submitted by Anonymous (not verified) on 28 May 2026 - 14:45
20 years supporting small and medium enterprises (SMEs) at EMA report
Product Management Services (PMS) - Implementation of International Organization for Standardization (ISO) standards for the identification of medicinal products (IDMP) in Europe - Chapter 3
Submitted by Anonymous (not verified) on 28 May 2026 - 14:30
Product Management Services (PMS) - Implementation of International Organization for Standardization (ISO) standards for the identification of medicinal products (IDMP) in Europe - Chapter 3
Timetable: Marketing authorisation renewal application - ATMP
Submitted by Anonymous (not verified) on 28 May 2026 - 14:25
Timetable: Marketing authorisation renewal application - ATMP
Timetable: Marketing authorisation renewal application
Submitted by Anonymous (not verified) on 28 May 2026 - 14:20
Timetable: Marketing authorisation renewal application
PSUSA/00002478/202508
Submitted by Anonymous (not verified) on 28 May 2026 - 12:18
PSUSA/00002478/202508
PSUSA/00001819/202509
Submitted by Anonymous (not verified) on 27 May 2026 - 15:18
PSUSA/00001819/202509
European Medicines Agency (EMA) / European Chemicals Agency (ECHA) joint meeting with industry stakeholders, Online, European Medicines Agency, Amsterdam, the Netherlands, from 9 June 2026, 09:00 (CEST) to 9 June 2026, 12:00 (CEST)
Submitted by Anonymous (not verified) on 27 May 2026 - 15:12
European Medicines Agency (EMA) / European Chemicals Agency (ECHA) joint meeting with industry stakeholders, Online, European Medicines Agency, Amsterdam, the Netherlands, from 9 June 2026, 09:00 (CEST) to 9 June 2026, 12:00 (CEST)
Accelerating Clinical Trials in the EU (ACT EU)
Submitted by Anonymous (not verified) on 27 May 2026 - 15:00
Accelerating Clinical Trials in the EU (ACT EU)
Human medicines European public assessment report (EPAR): Sunosi, solriamfetol, Date of authorisation: 16/01/2020, Revision: 11, Status: Authorised
Submitted by Anonymous (not verified) on 27 May 2026 - 14:40
Human medicines European public assessment report (EPAR): Sunosi, solriamfetol, Date of authorisation: 16/01/2020, Revision: 11, Status: Authorised